• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Secondary prevention in acute myocardial infarction.

作者信息

Mehta R H, Eagle K A

机构信息

University of Michigan Hospital, Division of Cardiology, Taubman Center, Ann Arbor 48109-0366, USA.

出版信息

BMJ. 1998 Mar 14;316(7134):838-42. doi: 10.1136/bmj.316.7134.838.

DOI:10.1136/bmj.316.7134.838
PMID:9549457
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1112771/
Abstract
摘要

相似文献

1
Secondary prevention in acute myocardial infarction.急性心肌梗死的二级预防
BMJ. 1998 Mar 14;316(7134):838-42. doi: 10.1136/bmj.316.7134.838.
2
Pathophysiologic bases for adjunctive therapies in the treatment and secondary prevention of acute myocardial infarction.急性心肌梗死治疗及二级预防中辅助治疗的病理生理基础。
Clin Cardiol. 1998 Mar;21(3):161-8. doi: 10.1002/clc.4960210305.
3
Prevention of myocardial reinfarction. Recommendations based on results of drug trials.
Postgrad Med. 1993 Nov 1;94(6):94-8, 102-4.
4
Adjunctive therapy for myocardial infarction.心肌梗死的辅助治疗
Arq Bras Cardiol. 1995 Jul;65(1):97-110.
5
[Drug therapy as secondary prevention following myocardial infarction].
Praxis (Bern 1994). 1996 Apr 23;85(17):545-7.
6
[Secondary prevention after myocardial infarction].[心肌梗死后的二级预防]
Kardiologiia. 1993;33(4):72-9.
7
Pharmacologic therapies after myocardial infarction.心肌梗死后的药物治疗。
Am J Med. 1996 Oct 8;101(4A):4A61S-69S; discussion 4A69S-70S. doi: 10.1016/s0002-9343(96)00322-1.
8
[Treatment after myocardial infarction].[心肌梗死后的治疗]
Presse Med. 1994 Feb 26;23(8):380-4.
9
[Secondary prevention after myocardial infarct].
Dtsch Med Wochenschr. 1990 Oct 5;115(40):1519-27. doi: 10.1055/s-2008-1065187.
10
[Adjuvant therapy in acute myocardial infarction: evidence based recommendations].[急性心肌梗死的辅助治疗：基于证据的推荐意见]
Rev Assoc Med Bras (1992). 2000 Oct-Dec;46(4):363-8. doi: 10.1590/s0104-42302000000400038.

引用本文的文献

1
Ten-year trends in lipid management among patients after myocardial infarction in South Korea.韩国心肌梗死后患者的血脂管理十年趋势。
PLoS One. 2024 Oct 3;19(10):e0304710. doi: 10.1371/journal.pone.0304710. eCollection 2024.
2
The Effects of Clinical Pharmacist Education on Lifestyle Modifications of Postmyocardial Infarction Patients in South India: A Prospective Interventional Study.临床药师教育对印度南部心肌梗死后患者生活方式改变的影响：一项前瞻性干预研究。
Curr Ther Res Clin Exp. 2020 Jan 30;92:100577. doi: 10.1016/j.curtheres.2020.100577. eCollection 2020.
3
Use of secondary prevention pharmacotherapy after first myocardial infarction in patients with diabetes mellitus.糖尿病患者首次心肌梗死后的二级预防药物治疗。
BMC Cardiovasc Disord. 2014 Jan 9;14:4. doi: 10.1186/1471-2261-14-4.
4
Differential associations between actual and expected GP practice prescribing rates for statins, ACE inhibitors, and beta-blockers: a cross-sectional study in England.实际和预期的全科医生处方他汀类药物、ACE 抑制剂和β受体阻滞剂的比率之间的差异关联：英格兰的一项横断面研究。
Ther Clin Risk Manag. 2005 Mar;1(1):61-8. doi: 10.2147/tcrm.1.1.61.53599.
5
Effect of drug combinations on admission for recurrent myocardial infarction.药物组合对复发性心肌梗死入院情况的影响。
Heart. 2007 Oct;93(10):1226-30. doi: 10.1136/hrt.2006.098053. Epub 2007 May 13.
6
Secondary prevention following myocardial infarction: evidence from an audit in South Wales that the National Service Framework for coronary heart disease does not address all the issues.心肌梗死后的二级预防：来自南威尔士一项审计的证据表明，冠心病国家服务框架并未涵盖所有问题。
Qual Saf Health Care. 2002 Sep;11(3):230-2. doi: 10.1136/qhc.11.3.230.
7
Comparison of estimates and calculations of risk of coronary heart disease by doctors and nurses using different calculation tools in general practice: cross sectional study.全科医疗中医生和护士使用不同计算工具对冠心病风险的评估与计算比较：横断面研究
BMJ. 2002 Feb 23;324(7335):459-64. doi: 10.1136/bmj.324.7335.459.
8
Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 3: Angiotensin-converting-enzyme inhibitors.选择高血压管理中的一线药物：证据有哪些？3：血管紧张素转换酶抑制剂。
CMAJ. 2000 Aug 8;163(3):293-6.
9
Current concepts in secondary prevention after acute myocardial infarction.急性心肌梗死后二级预防的当前概念。
Herz. 2000 Feb;25(1):47-60. doi: 10.1007/BF03044123.
10
Effect of postal prompts to patients and general practitioners on the quality of primary care after a coronary event (POST): randomised controlled trial.向患者及全科医生发送邮政提示对冠心病事件后初级保健质量的影响（POST）：随机对照试验
BMJ. 1999 Jun 5;318(7197):1522-6. doi: 10.1136/bmj.318.7197.1522.

本文引用的文献

1
ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).美国心脏病学会/美国心脏协会急性心肌梗死患者管理指南。美国心脏病学会/美国心脏协会实践指南工作组（急性心肌梗死管理委员会）报告。
J Am Coll Cardiol. 1996 Nov 1;28(5):1328-428. doi: 10.1016/s0735-1097(96)00392-0.
2
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.普伐他汀对胆固醇水平正常的心肌梗死患者冠状动脉事件的影响。胆固醇与再发事件试验研究人员。
N Engl J Med. 1996 Oct 3;335(14):1001-9. doi: 10.1056/NEJM199610033351401.
3
Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II).国家胆固醇教育计划（NCEP）成人高血胆固醇检测、评估与治疗专家小组（成人治疗小组第二次报告）总结。
JAMA. 1993 Jun 16;269(23):3015-23.
4
Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.抗血小板治疗随机试验的协作综述——I：各类患者长期抗血小板治疗预防死亡、心肌梗死和中风。抗血小板试验协作组。
BMJ. 1994 Jan 8;308(6921):81-106.
5
Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.雷米普利对伴有心力衰竭临床证据的急性心肌梗死幸存者死亡率和发病率的影响。急性梗死雷米普利疗效（AIRE）研究调查组。
Lancet. 1993 Oct 2;342(8875):821-8.
6
The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators.血管紧张素转换酶抑制剂佐芬普利对前壁心肌梗死后死亡率和发病率的影响。心肌梗死长期评估生存（SMILE）研究组。
N Engl J Med. 1995 Jan 12;332(2):80-5. doi: 10.1056/NEJM199501123320203.
7
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).4444例冠心病患者降胆固醇随机试验：斯堪的纳维亚辛伐他汀生存研究（4S）
Lancet. 1994 Nov 19;344(8934):1383-9.
8
GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico.GISSI-3研究：赖诺普利与经皮硝酸甘油单独及联合应用对急性心肌梗死后6周死亡率及心室功能的影响。意大利心肌梗死存活研究组
Lancet. 1994 May 7;343(8906):1115-22.
9
Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1).
Lancet. 1995 Mar 18;345(8951):686-7.
10
ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.ISIS-4：一项随机析因试验，在58050例疑似急性心肌梗死患者中评估早期口服卡托普利、口服单硝酸酯和静脉注射硫酸镁。ISIS-4（第四次国际心肌梗死存活研究）协作组
Lancet. 1995 Mar 18;345(8951):669-85.